Literature DB >> 31726735

Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121.

Amaal Eman Abdulle1, Harry van Goor2, Douwe J Mulder1.   

Abstract

The authors wish to make the following correction to this paper [...].

Entities:  

Year:  2019        PMID： 31726735      PMCID： PMC6887776          DOI： 10.3390/ijms20225663

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN： 1422-0067            Impact factor:   5.923


The authors wish to make the following correction to this paper [1]. Reference [8] refers to the wrong article. The correct reference [2] should be: Abdulle, A.E.; Diercks, G.F.H.; Feelisch, M.; Mulder, D.J.; van Goor, H. The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy. Front. Physiol. 2018, 9, 1–15, doi:10.3389/fphys.2018.01177. The authors would like to apologize for any inconvenience caused to the readers by these changes.
  2 in total

Review 1.  The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy.

Authors:  Amaal E Abdulle; Gilles F H Diercks; Martin Feelisch; Douwe J Mulder; Harry van Goor
Journal:  Front Physiol       Date:  2018-08-24       Impact factor: 4.566

Review 2.  Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis.

Authors:  Amaal Eman Abdulle; Harry van Goor; Douwe J Mulder
Journal:  Int J Mol Sci       Date:  2018-12-19       Impact factor: 5.923
  2 in total
  1 in total

1.  SG1002 and Catenated Divalent Organic Sulfur Compounds as Promising Hydrogen Sulfide Prodrugs.

Authors:  Gabriel Gojon; Guillermo A Morales
Journal:  Antioxid Redox Signal       Date:  2020-06-11       Impact factor: 8.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.